UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 166

Sortiert nach

When prospective randomised trials have unexpected results: where do we go from there?

BJOG : an international journal of obstetrics and gynaecology, 2019-07, Vol.126 (8), p.960-960

Duska, LR

2019

Link zum Volltext

Verfügbarkeit prüfen

Surgery is critical to a multidisciplinary approach to ovarian cancer

BJOG : an international journal of obstetrics and gynaecology, 2018-09, Vol.125 (10), p.1253-1253

Duska, LR

2018

Link zum Volltext

Verfügbarkeit prüfen

Recognising endometrial cancer in pre‐menopausal women

BJOG : an international journal of obstetrics and gynaecology, 2017-02, Vol.124 (3), p.412-412

Duska, LR

2017

Link zum Volltext

Verfügbarkeit prüfen

Stuck in the middle: diagnostic and clinical management challenges surrounding CIN2

BJOG : an international journal of obstetrics and gynaecology, 2020-05, Vol.127 (6), p.737-737

2020

Link zum Volltext

Verfügbarkeit prüfen

Granulosa cell tumours of the ovary: the challenges of studying a rare tumour

BJOG : an international journal of obstetrics and gynaecology, 2017-01, Vol.124 (1), p.149-149

Duska, LR

2017

Link zum Volltext

Verfügbarkeit prüfen

The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications

Annals of oncology, 2017-11, Vol.28 (suppl_8), p.viii8-viii12

2017

Link zum Volltext

Verfügbarkeit prüfen

PET trumps surgical staging in locally advanced cervical cancer

BJOG : an international journal of obstetrics and gynaecology, 2017-06, Vol.124 (7), p.1095-1095

2017

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium

Gynecologic oncology, 2022-07, Vol.166 (1), p.44-49

2022

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma

Gynecologic oncology, 2020-06, Vol.157 (3), p.585-592

2020

Link zum Volltext

Verfügbarkeit prüfen

A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer

Gynecologic oncology, 2021-03, Vol.160 (3), p.688-695

2021

Link zum Volltext

Verfügbarkeit prüfen

Combination photoimmunotherapy and cisplatin : Effects on human ovarian cancer ex vivo

JNCI : Journal of the National Cancer Institute, 1999-09, Vol.91 (18), p.1557-1563

1999

Link zum Volltext

Verfügbarkeit prüfen

A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer

Gynecologic oncology, 2017-11, Vol.147 (2), p.276-282

2017

Link zum Volltext

Verfügbarkeit prüfen

Novel small-molecule RORγ agonist immuno-oncology agent LYC-55716: Safety and efficacy in a phase IIA open-label, multicenter trial

Annals of oncology, 2018-10, Vol.29, p.viii404-viii405

2018

Link zum Volltext

Verfügbarkeit prüfen

Epithelial ovarian carcinoma in the reproductive age group

Cancer, 1999-06, Vol.85 (12), p.2623-2629

1999

Link zum Volltext

Verfügbarkeit prüfen

Treatment of uterine papillary serous carcinoma with platinum‐based chemotherapy and paclitaxel

International journal of gynecological cancer, 2006-02, Vol.16 (S1), p.267-272

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical Evaluation of Atypical Glandular Cells of Undetermined Significance on Cervical Cytology

Obstetrics and gynecology (New York. 1953), 1998-02, Vol.91 (2), p.278-282

1998

Link zum Volltext

Verfügbarkeit prüfen

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

Cancer, 2000-10, Vol.89 (7), p.1532-1540

2000

Link zum Volltext

Verfügbarkeit prüfen

Endometrial Cancer in Women 40 Years Old or Younger

Gynecologic oncology, 2001-11, Vol.83 (2), p.388-393

2001

Link zum Volltext

Verfügbarkeit prüfen

BAG-1 expression in normal and neoplastic endometrium

Gynecologic oncology, 2004-08, Vol.94 (2), p.289-295

2004

Link zum Volltext

Verfügbarkeit prüfen

Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer

British journal of cancer, 1997, Vol.75 (6), p.837-844

1997

Link zum Volltext

Verfügbarkeit prüfen

Updated Findings and Biomarker Analysis From the Ongoing Phase 1 Study of Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors

European journal of cancer (1990), 2022-10, Vol.174, p.S67-S67

2022

Link zum Volltext

Verfügbarkeit prüfen

Preliminary Clinical Data From Ongoing Phase 2 Study With Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors or Hematologic Malignancies

European journal of cancer (1990), 2022-10, Vol.174, p.S31-S32

2022

Link zum Volltext

Verfügbarkeit prüfen

Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease

Gynecologic oncology, 1995-11, Vol.59 (2), p.179-182

1995

Link zum Volltext

Verfügbarkeit prüfen

The Role of Cytoreductive Surgery in the Management of Stage IV Uterine Papillary Serous Carcinoma

Gynecologic oncology, 2001-04, Vol.81 (1), p.92-99

2001

Link zum Volltext

Verfügbarkeit prüfen

Fertility options for patients with stages ia2 and ib cervical cancer: presentation of two cases and discussion of technical and ethical issues

Obstetrics and gynecology (New York. 1953), 1998-10, Vol.92 (4), p.656-658

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 166

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(139)

Publikationsform

Artikel
(160)
Buchkapitel
(6)

Sprache

Englisch
(166)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

When prospective randomised trials have unexpected results: where do we go from there?

Surgery is critical to a multidisciplinary approach to ovarian cancer

Recognising endometrial cancer in pre‐menopausal women

Stuck in the middle: diagnostic and clinical management challenges surrounding CIN2

Granulosa cell tumours of the ovary: the challenges of studying a rare tumour

The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications

PET trumps surgical staging in locally advanced cervical cancer

A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium

A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma

A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer

Combination photoimmunotherapy and cisplatin : Effects on human ovarian cancer ex vivo

A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer

Novel small-molecule RORγ agonist immuno-oncology agent LYC-55716: Safety and efficacy in a phase IIA open-label, multicenter trial

Epithelial ovarian carcinoma in the reproductive age group

Treatment of uterine papillary serous carcinoma with platinum‐based chemotherapy and paclitaxel

Clinical Evaluation of Atypical Glandular Cells of Undetermined Significance on Cervical Cytology

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography

Endometrial Cancer in Women 40 Years Old or Younger

BAG-1 expression in normal and neoplastic endometrium

Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer

Updated Findings and Biomarker Analysis From the Ongoing Phase 1 Study of Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors

Preliminary Clinical Data From Ongoing Phase 2 Study With Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors or Hematologic Malignancies

Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease

The Role of Cytoreductive Surgery in the Management of Stage IV Uterine Papillary Serous Carcinoma

Fertility options for patients with stages ia2 and ib cervical cancer: presentation of two cases and discussion of technical and ethical issues

Suchergebnisse filtern